Intellectus Partners LLC Cuts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Intellectus Partners LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 7.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,705 shares of the financial services provider’s stock after selling 1,051 shares during the period. Intellectus Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,995,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in IBB. OneDigital Investment Advisors LLC raised its position in iShares Biotechnology ETF by 32.7% in the third quarter. OneDigital Investment Advisors LLC now owns 10,805 shares of the financial services provider’s stock worth $1,573,000 after acquiring an additional 2,661 shares in the last quarter. Sargent Investment Group LLC acquired a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth $211,000. Snider Financial Group increased its holdings in shares of iShares Biotechnology ETF by 19.8% in the 3rd quarter. Snider Financial Group now owns 24,000 shares of the financial services provider’s stock valued at $3,494,000 after purchasing an additional 3,970 shares in the last quarter. Huntington National Bank lifted its stake in shares of iShares Biotechnology ETF by 17.9% in the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock valued at $153,000 after purchasing an additional 160 shares during the period. Finally, Florin Court Capital LLP boosted its holdings in iShares Biotechnology ETF by 570.3% during the third quarter. Florin Court Capital LLP now owns 24,800 shares of the financial services provider’s stock worth $3,611,000 after buying an additional 21,100 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $140.09 on Friday. The firm’s 50-day moving average is $144.68 and its two-hundred day moving average is $141.56. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.